Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ophth. Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ophth. Other
    FDA Approves Triamcinolone Acetone Formulation for Ocular Use - (DGNews)
    Adalimumab Cuts Uveitis Flares: Presented at EULAR - (DGDispatch)
    Diabetes Medication Associated With Slower Progression of Retina Disease - (DGNews)
    Patients With Graves' Disease Treated With Radioiodine I-131 at Risk of Graves' Ophthalmology: Presented at ECE - (DGDispatch)
    More Patients With Macular Degeneration Driving Their Cars After Treatment With Ranibizumab Than With Photodynamic Therapy: Presented at ARVO - (DGDispatch)

    News archive

     Recent webcasts/CME - Ophth. Other
    • Data Continue to Modify Guidelines for Immunomodulatory Therapy in Multiple Sclerosis
    • Targeted Therapies Demonstrate Efficacy in Multiple Sclerosis
    • New Perspectives on Allergy Management: Ophthalmologists and Allergists Weigh in on Key Issues
      Combination Therapies for the Treatment of AMD
      Managing Concomitant Eye Diseases: Expert Views on Glaucoma and Dry Eye

      Webcasts/CME archive

       Recent cases - Ophth. Other
        An Atypical Presentation of Cystic Fibrosis: A Case Report
        Lateral Rectus Metastasis from an Occult Systemic Malignancy Masquerading as Abducens Palsy: A Case Report
        Spontaneous Resolution of Congenital Brown's Syndrome - A Case Report
        Use of Intravitreal Bevacizumab in a Patient with a Von Hippel-Lindau-Associated Retinal Haemangioblastoma of the Optic Nerve Head: A Case Report
        Clear Lens Phacoemulsification in Anterior Lenticonus Due to Alport Syndrome: Two Case Reports

        Cases archive
          




        my personal edition > ophth. other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Increasing Retinal Antioxidant Levels Might Influence Macular Function

        A DGReview of :"Influence of short-term antioxidant supplementation on macular function in age-related maculopathy. A pilot study including electrophysiologic assessment."
        Ophthalmology

        01/20/2003
        By Mark Greener


        Increasing antioxidant levels in the retina might influence macular function in early age-related maculopathy as well as during normal aging.

        Researchers from the Universita Cattolica del S Cuore, Rome, Italy, enrolled 30 patients with early age-related maculopathy and a visual acuity of at least 20/30 as well as eight age-matched normal controls.

        Seventeen patients and four controls received oral lutein 15 mg; vitamin E 20 mg; nicotinamide 18 mg for 180 days. Eight patients with age-related maculopathy took the antioxidants for a further 180 days. The remaining patients and controls did not receive supplements.

        After 180 days, focal electroretinograms (FERGs) showed increased amplitude compared to baseline in patients and controls that received the antioxidants (p</=0.01). Amplitude did not change in the untreated patients and controls. Modulation thresholds on FERGs decreased compared to baseline in the patients who took antioxidants, but not in the untreated patients (p<0.01). However, FERG phase did not alter in any group.

        After 360 days, the FERG amplitude remained elevated compared to baseline (p<0.05). However, the increase was no more marked than after 180 days. One patient discontinued supplementation after 180 days. In this patient, FERG amplitude decreased from the value after 180 days and approached the baseline value.

        The authors comment that this study does not offer any evidence that long-term antioxidant supplementation will benefit age-related maculopathy patients. However, they conclude that increasing antioxidant levels in the retina might influence macular function in early ARM as well as during normal aging.
        Ophthalmology 2003;110:51-60. "Influence of short-term antioxidant supplementation on macular function in age-related maculopathy. A pilot study including electrophysiologic assessment."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send